Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Browne

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
The American Journal of Cardiology|May 15, 1995
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarctionG W Stone, C L Grines, K F Browne, et al.
American Heart Journal|May 1, 1982
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrodeD P Zipes, W M Jackman, J J Heger, et al.
Journal of the American College of Cardiology|July 1, 1995
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplastyG W Stone, C L Grines, K F Browne, et al.
The Journal of Invasive Cardiology|April 4, 2000
Worse six-month outcome for patients with multiple stents in a single coronary arteryE Gaxiola, R E Vlietstra, K F Browne, et al.
Nature Communications|February 21, 2025
Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathyDanielle F Browne, Denis S Smirnov, David G Coughlin, et al.
Circulation|January 1, 1991
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study InvestigatorsJ L Anderson, S G Sorensen, F L Moreno, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 5, 2020
Transforming Positive Pressure IR Suites to Treat COVID-19 PatientsNicole A Lamparello, Sarah Choi, Resmi Charalel, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|June 1, 1988
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinaseJ L Anderson, R L Rothbard, R A Hackworthy, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
The American Journal of Cardiology|May 15, 1995
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarctionG W Stone, C L Grines, K F Browne, et al.
American Heart Journal|May 1, 1982
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrodeD P Zipes, W M Jackman, J J Heger, et al.
Journal of the American College of Cardiology|July 1, 1995
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplastyG W Stone, C L Grines, K F Browne, et al.
The Journal of Invasive Cardiology|April 4, 2000
Worse six-month outcome for patients with multiple stents in a single coronary arteryE Gaxiola, R E Vlietstra, K F Browne, et al.
Nature Communications|February 21, 2025
Early Alzheimer's Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathyDanielle F Browne, Denis S Smirnov, David G Coughlin, et al.
Circulation|January 1, 1991
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study InvestigatorsJ L Anderson, S G Sorensen, F L Moreno, et al.
Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 5, 2020
Transforming Positive Pressure IR Suites to Treat COVID-19 PatientsNicole A Lamparello, Sarah Choi, Resmi Charalel, et al.
Journal of the American College of Cardiology|March 18, 1999
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trialC M Nunn, W W O'Neill, D Rothbaum, et al.
Journal of the American College of Cardiology|June 1, 1988
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinaseJ L Anderson, R L Rothbard, R A Hackworthy, et al.
Pageof 16